MX9700939A - PROCESO PARA PREPARAR CLATRATO DE FREON- beta DE DIPROPIONATO DE BECLOMETASONA. - Google Patents

PROCESO PARA PREPARAR CLATRATO DE FREON- beta DE DIPROPIONATO DE BECLOMETASONA.

Info

Publication number
MX9700939A
MX9700939A MX9700939A MX9700939A MX9700939A MX 9700939 A MX9700939 A MX 9700939A MX 9700939 A MX9700939 A MX 9700939A MX 9700939 A MX9700939 A MX 9700939A MX 9700939 A MX9700939 A MX 9700939A
Authority
MX
Mexico
Prior art keywords
clathrate
beclomethasone dipropionate
freon
preparing
dipropionate freon
Prior art date
Application number
MX9700939A
Other languages
English (en)
Inventor
George M Love
Stanley Rosenhouse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9700939A publication Critical patent/MX9700939A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S95/00—Gas separation: processes
    • Y10S95/90—Solid sorbent
    • Y10S95/902—Molecular sieve

Abstract

Se describe un proceso para preparar clatrato de Freon de dipropionato de beclometasona que comprende el uso de un agente que liga selectivamente el metanol para remover selectivamente el metanol de una mezcla de metanol y Freon 11, que contiene dipropionato de beclometasona.
MX9700939A 1994-08-09 1995-08-04 PROCESO PARA PREPARAR CLATRATO DE FREON- beta DE DIPROPIONATO DE BECLOMETASONA. MX9700939A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28757694A 1994-08-09 1994-08-09
PCT/US1995/009678 WO1996004889A1 (en) 1994-08-09 1995-08-04 Process for preparing beclomethasone dipropionate freon® clathrate

Publications (1)

Publication Number Publication Date
MX9700939A true MX9700939A (es) 1997-04-30

Family

ID=23103513

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700939A MX9700939A (es) 1994-08-09 1995-08-04 PROCESO PARA PREPARAR CLATRATO DE FREON- beta DE DIPROPIONATO DE BECLOMETASONA.

Country Status (8)

Country Link
US (1) US6436368B1 (es)
EP (1) EP0774956A1 (es)
JP (1) JP3119487B2 (es)
AU (1) AU693590B2 (es)
CA (1) CA2196171A1 (es)
MX (1) MX9700939A (es)
NZ (1) NZ291559A (es)
WO (1) WO1996004889A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69736981D1 (de) * 1996-05-01 2007-01-04 Imarx Pharmaceutical Corp In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
US10422137B2 (en) * 2016-11-28 2019-09-24 Korea Institute Of Civil Engineering And Building Technology Heat shrinkable tube-covered rebar and method of preventing rebar from corroding using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
JPS61145274A (ja) * 1984-12-19 1986-07-02 Mitsubishi Heavy Ind Ltd 蓄冷剤
US4864012A (en) * 1985-12-23 1989-09-05 The Dow Chemical Company Process for the removal of a solute from a solution

Also Published As

Publication number Publication date
CA2196171A1 (en) 1996-02-22
AU693590B2 (en) 1998-07-02
EP0774956A1 (en) 1997-05-28
US6436368B1 (en) 2002-08-20
WO1996004889A1 (en) 1996-02-22
JPH09508647A (ja) 1997-09-02
JP3119487B2 (ja) 2000-12-18
AU3273095A (en) 1996-03-07
NZ291559A (en) 1998-09-24

Similar Documents

Publication Publication Date Title
AU6477390A (en) Gas generating compositions containing nitrotriazalone
NO845194L (no) Flertrinnskombinasjonspreparat og anvendelse av dette som oralt antikonsepsjonsmiddel
AU5207690A (en) Azide gas generating composition for inflatable devices
DE69533190D1 (de) Behandlung von pulmonaler vasokonstriktion und asthma
AU1503088A (en) Foamed air freshener composition
IL81802A (en) Cyclodextrin clathrates of carbacyclin analogs and pharmaceutical compositions containing the same
BG101714A (en) Improvements in the function of the endometrium or in functions related to it
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
EP0646007A1 (en) NEW DELTA-17 AND DELTA-20 UNSATURATED AND SATURATED 17 - g (b) -SUBSTITUTED-4-AZA-5-g (a) -ANDROSTAN-3-ON COMPOUNDS AS INHIBITORS OF 5-ALPHA REDUCTASE.
AU1294992A (en) Manufacture of rigid foams and compositions therefor
GB9505623D0 (en) Process for the preparation of gas-generating compositions
MY101804A (en) Menthol soap
GB2294401B (en) Generation of an aerosol of an exact dose
MY115533A (en) Benzothiophenes, formulation containing same and methods
MX9700939A (es) PROCESO PARA PREPARAR CLATRATO DE FREON- beta DE DIPROPIONATO DE BECLOMETASONA.
AU562683B2 (en) Synthesis of methyl 2-benzimidazolcarbamate
GB2250158B (en) Operating apparatus of an audio mixer
EP0585168A3 (en) Composition and methods for the generation of bone
AU8503191A (en) Azeotrope-like compositions of 1,1-dichloro-1-fluoroethane; dichlorotrifluoroethane; methanol; and alkene having 5 carbon atoms
HUP9702477A3 (en) New polymorphous form of doxazosin-mesylate (form iii), process for it's preparation and pharmaceutical compositions containing the same
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
HU9601498D0 (en) Use of dimeticone for treating constipation
TW342311B (en) Fungicidal mixtures
AU6951494A (en) Process for the manfuacture of linear hydrofluorocarbons containing end group hydrogen substituents and azeotropes thereof
AU3191889A (en) 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use